Praxis Precision Medicines

Traded on the St. Petersburg Stock Exchange
Praxis Precision Medicines is an American clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders characterized by neuronal imbalance. The company was incorporated in 2015 and is based in Cambridge, Massachusetts.
Praxis Precision Medicines stock price chart
vol.
change
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Praxis Precision Medicines balance sheet

Report period20182019 2020 2021 2022 Q3 23
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Praxis Precision Medicines cash flows

Report period20182019 2020 2021 2022
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

Praxis Precision Medicines multipliers

Report period20182019 2020 2021 2022 Q3 23 TTM
P/E
E/P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Praxis Precision Medicines profitability

Report period20182019 2020 2021 2022 Q3 23 TTM
ROA
ROE
ROS
EBITDA Margin
Operating margin
Praxis Precision Medicines assets
Praxis Precision Medicines cash flows

Praxis Precision Medicines dividend policy

The company doesn't provide dividend

Praxis Precision Medicines shares

TickerNameTypeNominal valueISINPrice
PRAX:USPraxis Precision MedicinesCommon share-US74006W1080$77.88
Praxis Precision Medicines news
10.05.2022
Praxis Precision Medicines' GAAP loss for 3 months of 2022 was $68.717 million, up 2.5 times from $27.373 million in the previous year.
Source: investors.praxismedicines.com pictogram investors.praxismedicines.com
Pictogram next
28.02.2022
Praxis Precision Medicines' GAAP loss for 2021 was $167.061 million, up 2.7 times from $61.82 million in the previous year.
Source: investors.praxismedicines.com pictogram investors.praxismedicines.com
Pictogram next
03.11.2021
Praxis Precision Medicines' GAAP loss for 9M 2021 was $108.479 million, up three times from $36.114 million in the previous year.
Source: investors.praxismedicines.com pictogram investors.praxismedicines.com
Pictogram next
16.08.2021
Praxis Precision Medicines' GAAP loss for 6M 2021 was $63.774 million, up 3.2 times from $19.898 million in the previous year.
Source: investors.praxismedicines.com pictogram investors.praxismedicines.com
Pictogram next
All Praxis Precision Medicines news
General information
Company namePraxis Precision Medicines
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Biotechnology / Biotechnology
Business address1 Broadway 16th Floor Cambridge, MA 02142 United States
Mailing address1 Broadway 16th Floor Cambridge, MA 02142 United States
Websiteinvestors.praxismedicines.com
Information disclosurewww.sec.gov